Analytical exoglycosidases are transitioning from being largely academic tools to being suitable for glycan analytics in biopharmaceutical manufacturing.
Ian Walsh
Advertisement
Ian Walsh is an associate staff scientist at Bioprocessing Technology Institute, Agency for Science, Technology and Research.
Articles by Ian Walsh
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
4
FDA Expands Anktiva Approval to Papillary-Only BCG-Unresponsive Bladder Cancer
5